Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure
Clinical trial NCT00025727 · UNKNOWN
Trial details
- NCT number
- NCT00025727
- Sponsor
- GlaxoSmithKline
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-05-01
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.